Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease

Qing-Yan Zhang1, Chun-Ming Jiang, Cheng Sun

  • 1Department of Nephrology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, 321 Zhong Shan Road, Nanjing, 210008, China.

Journal of Nephrology
|December 18, 2014
PubMed

Insights

Low vitamin D levels (hypovitaminosis D) are linked to impaired blood vessel function (endothelial dysfunction) in chronic kidney disease patients. This association highlights a potential target for improving cardiovascular health in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Cardiovascular disease is a major concern in chronic kidney disease (CKD).
  • Both hypovitaminosis D and endothelial dysfunction are prevalent in CKD patients and are linked to cardiovascular risks.

Purpose of the Study:

  • To investigate the relationship between vitamin D deficiency and endothelial dysfunction in individuals with non-dialysis-dependent CKD.

Main Methods:

  • Endothelial function was assessed in 117 non-dialysis CKD patients using brachial artery flow-mediated dilation (FMD), soluble vascular cell adhesion molecule-1 (sVCAM-1), and sE-selectin.
  • Serum levels of 25-hydroxyvitamin D [25(OH)D] were measured.

Main Results:

  • Lower FMD and higher levels of sVCAM-1 and sE-selectin were observed in patients with vitamin D deficiency or insufficiency compared to those with sufficient levels.
  • A significant positive correlation was found between FMD and 25(OH)D levels (r=0.556, p<0.001).
  • Significant negative correlations were observed between sVCAM-1 (r=-0.549, p<0.001) and sE-selectin (r=-0.360, p<0.001) and 25(OH)D levels, even after adjusting for confounders.

Conclusions:

  • Hypovitaminosis D is associated with endothelial dysfunction in non-dialysis CKD patients.
  • Further research is warranted to explore the potential benefits of vitamin D supplementation for improving endothelial function and reducing cardiovascular events in this patient group.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
669
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K